Intratumoral Transforming Boron Nanosensitizers for Amplified Boron Neutron Capture Therapy
Angewandte Chemie International Edition · 2025
DOI: 10.1002/anie.202413232 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Liping Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Radiology Department of Shanxi Provincial People's Hospital Affiliated to, Shanxi Medical University, Taiyuan, 030001, P. R. China. Hauptthemen laut MEDLINE: Boron Neutron Capture Therapy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Boron neutron capture therapy (BNCT) is an advanced binary tumor‐cell‐selected heavy‐particle radiotherapy used for treating invasive malignant tumors. However, its clinical applications have been impeded by the rapid metabolism and insufficient tumor‐specific accumulation of boron agents. To tackle this issue, we develop a smart boron nanosensitizer (BATBN) capable of transforming its size in response to cancer biomarker for optimal balance between penetration and retention of boron‐10 for BNCT. BATBN comprises an ultrasmall boron quantum dots (BQD) core (4 nm) conjugated with cell‐penetrating peptides, which facilitates its cellular uptake and deep tumor penetration. In the tumor microenvironment, the tumor biomarker can specifically initiate a self‐condensation reaction of BATBN, leading to the formation of larger‐sized nanoaggregates. Due to such a specific intratumoral transformation, BATBN demonstrates a 2.4‐fold increase in intratumoral boron concentration and a 5.0‐fold increase in tumor retention time compared to the BQDs. Thus, the tumor volume of the BATBNs‐treatment group is 2.7‐fold smaller than that of BQDs in preclinical tumor models after 21 days of neutron irradiation treatment. This study presents a supramolecular strategy to endow BNCT agents with the biomarker‐activated size interconversion, permitting precise and efficient BNCT for cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Radiology Department of Shanxi Provincial People's Hospital Affiliated to, Shanxi Medical University, Taiyuan, 030001, P. R. China.
- Department of Chemistry, Basic Medical College, Shanxi Medical University, Taiyuan, 030001, P. R. China.
- Key Laboratory of Interface Science and Engineering in Advanced Materials, Ministry of Education, Taiyuan University of Technology, Taiyuan, 030024, P. R. China.
- Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Taiyuan, 030032, P. R. China.
- Beijing Nuclear Industry Hospital, Beijing, 102413, P. R. China.
- Beijing Capture Tech Co., Ltd, Beijing, 102413, P. R. China.
ORCID-Profile: Kanyi Pu
Zitieren
APA
Li, L., Wang, M., Zhao, Q., Bai, P., Hao, H., Zhang, Z., Liu, T., Yang, Y., Pu, K., & Zhang, R. (2025). Intratumoral Transforming Boron Nanosensitizers for Amplified Boron Neutron Capture Therapy. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202413232
Vancouver
Li L, Wang M, Zhao Q, Bai P, Hao H, Zhang Z, et al. Intratumoral Transforming Boron Nanosensitizers for Amplified Boron Neutron Capture Therapy. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202413232
BibTeX
@article{Li2025,
author = {Li, Liping and Wang, Mixue and Zhao, Qian and Bai, Peirong and Hao, Haotian and Zhang, Zizhu and Liu, Tong and Yang, Yongzhen and Pu, Kanyi and Zhang, Ruiping},
title = {Intratumoral Transforming Boron Nanosensitizers for Amplified Boron Neutron Capture Therapy},
journal = {Angewandte Chemie International Edition},
year = {2025},
doi = {10.1002/anie.202413232}
}
EUVIMED